Article PDF
Références
Onusida (2006) Rapport sur l’épidémie mondiale de sida: résumé d’orientation: Programme mondial des Nations Unies sur le VIH/sida (Onusida). Onusida/06.20F
Barré-Sinoussi F, Chermann JC, Rey F, et al (1983) Isolation of a Tlymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science. 220(4599): 868–871
Montagnier L (1994) Des virus et des hommes, Éditions Odile Jacob, 315p
Karpas A (2004) Human retroviruses in leukaemia and AIDS: reflections on their discovery, biology and epidemiology. Biol Rev Camb Philos Soc 79(4):911–933
Peeters M, Piot P, Van der Groen G (1991) Variability among HIV and SIV strains of African origin. AIDS 5(Suppl 1):S29–S36
Apetrei C, Robertson DL, Marx PA (2004) The history of SIVS and AIDS: epidemiology, phylogeny and biology of isolates from naturally SIV infected non-human primates (NHP). Afr Front Biosci 9:225–254
Marx PA, Apetrei C, Drucker E (2004) AIDS as a zoonosis? Confusion over the origin of the virus and the origin of the epidemics. J Med Primatol 33(5–6):220–226
Pandrea I, Silvestri G, Apetrei C (2009) AIDS in African nonhuman primate hosts of SIVs: a new paradigm of SIV infection. Curr HIV Res 7(1):57–72
Alizon M, Montagnier L (1987) Genetic variability in human immunodeficiency viruses. Ann NY Acad Sci 511:376–384
Grulich AE (2009) Living longer with HIV: what does it mean for cancer risk? Curr Opin HIV AIDS 4(1):1–2
Mbulaiteye SM, Parkin DM, Rabkin CS (2003) Epidemiology of AIDS-related malignancies an international perspective. Hematol Oncol Clin North Am 17(3):673–696
Yakam JC, Gruénais ME (2009) Involving new actors to achieve ART scaling-up: difficulties in an HIV/AIDS counselling and testing centre in Cameroon. Int Nurs Rev 56(1):50–57
Yaotsè DA, Nicole V, Roch NF, et al (2009) Genetic characterization of HIV-1 strains in Togo reveals a high genetic complexity and genotypic drug-resistance mutations in ARV naive patients. Infect Genet Evol 9(4):646–652
Onusida/OMS (2006) Élargissement de l’accès au traitement antirétroviral dans le monde: rapport sur l’initiative « trois millions d’ici 2005 », 2006, OMS
Maher D, Harries A, Getahun H (2009) Tuberculosis and HIV interaction in Sub-Saharan Africa: impact on patients and programmes; implications for policies. Trop Med Int Health 10(8): 734–742
Lieberman-Blum SS, Fung HB, Bandres JC (2008) Maraviroc: a CCR5-receptor antagonist for the treatment of HIV-1 infection. Clin Ther 30(7):1228–1250
Nies-Kraske E, Schacker TW, et al (2009) Evaluation of the pathogenesis of decreasing CD4(+) T cell counts in human immunodeficiency virus type 1-infected patients receiving successfully suppressive antiretroviral therapy. J Infect Dis 199(11):1648–1656
Engels EA, Biggar RJ, Hall HI, et al (2008) Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer 123(1):187–194
Mbulaiteye SM, Katabira ET, Wabinga H, et al (2006) Spectrum of cancers among HIV-infected persons in Africa: the Uganda AIDS-Cancer Registry Match Study. Int J Cancer 118(4): 985–990
Centre international de recherche sur le cancer (2008) Le cancer dans le monde en 2008. Centre international de recherche sur le cancer, Lyon
Centre international de recherche sur le cancer (2005) Le cancer dans le monde. Centre international de recherche sur le cancer, Lyon
Crum-Cianflone N, Hullsiek KH, Marconi V, et al (2009) Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study. AIDS 23(1):41–50
Weiss R (2006) Les tumeurs malignes associées au VIH/sida In: Ly A, Khayat D (eds) Le cancer en Afrique: de l’épidémiologie aux applications et perspectives de la recherche biomédicale. Institut national du cancer (INCa), Paris, pp. 479–489
Silverberg MJ, Abrams DI (2007) AIDS-defining and non- AIDS-defining malignancies: cancer occurrence in the antiretroviral therapy era. Curr Opin Oncol 19(5):446–451
Kahesa C, Mwaiselage J, Wabinga HR, et al (2008) Association between invasive cancer of the cervix and HIV-1 infection in Tanzania: the need for dual screening. BMC Public Health 8:26
IARC (1996) Monographs on the evaluation of carcinogenic risks to humans, vol 67 human immunodeficiency viruses and human T-cell lymphotropic viruses. Consultable http://monographs.iarc.fr/ENG/Monographs/vol67/mono67-5.pdf
Silverberg MJ, Abrams DI (2009) Do antiretrovirals reduce the risk of non-AIDS-defining malignancies? Curr Opin HIV AIDS 4(1):42–51
Burnet M (1957) Cancer: a biological approach. III. Viruses associated with neoplastic conditions. IV. Practical applications. Br Med J 1:841–847
Burnet FM (1970) The concept of immunological surveillance. Prog Exp Tumor Res 13: 1–27
Dunn GP, Old LJ, Schreiber RD (2004) The three Es of cancer immunoediting. Annu Rev Immunol 22:329–360
Teng MW, Swann JB, Koebel CM, et al (2008) Immune-mediated dormancy: equilibrium with cancer. J Leukoc Biol 84(4):988–993
Reiman JM, Kmieciak M, Manjili MH, Knutson KL (2009) Tumor immunoediting and immunosculpting pathways to cancer progression. Semin Cancer Biol 17(4):275–287
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Ly, A. Du VIH/sida aux tumeurs malignes associées. J Afr Cancer 1, 123–126 (2009). https://doi.org/10.1007/s12558-009-0024-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12558-009-0024-1